Cardiovascular calcifications in pediatric patients receiving maintenance dialysis

被引:15
作者
Sheth, RD
Perez, MD
Goldstein, SL
机构
[1] Texas Childrens Hosp, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Renal Sect, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pediat, Rheumatol Sect, Houston, TX 77030 USA
关键词
cardiovascular disease; calcifications; vasculitis; pediatric dialysis; renal osteodystrophy;
D O I
10.1007/s00467-003-1156-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cardiovascular disease is a major cause of morbidity and mortality in adult patients with end-stage renal disease receiving maintenance dialysis. Coronary artery calcifications (CAC) contribute to the high prevalence of cardiac disease and are associated with hyperphosphatemia, an elevated calcium-phosphorus product (CaxP), and prolonged time on dialysis. Chronic inflammation and malnutrition are also associated with an increased risk for development of cardiac calcifications. Young adults receiving maintenance dialysis develop cardiac calcifications at a degree out of proportion to healthy adults of the same age and gender. Many of these young adults initiated dialysis as children or teenagers. Risk factors associated with the development of CAC are also seen in the pediatric dialysis population. To date, reports of cardiac calcifications in pediatric patients receiving maintenance dialysis are limited to post-mortem studies. We present two pediatric patients with ANCA-positive vasculitis diagnosed with cardiac calcifications while receiving maintenance dialysis. Hyperphosphatemia and an elevated CaxP product were seen in both patients and probably contributed to the development of extraskeletal calcifications. In addition, both patients had an underlying systemic inflammatory disease and significant weight loss/malnutrition that may have contributed to the early and rapid onset of cardiac calcifications.
引用
收藏
页码:810 / 813
页数:4
相关论文
共 21 条
[1]  
Bergstrom J, 2000, Pol Arch Med Wewn, V104, P641
[2]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[3]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[4]   Cardiovascular disease in pediatric chronic dialysis patients [J].
Chavers, BM ;
Li, SL ;
Collins, AJ ;
Herzog, CA .
KIDNEY INTERNATIONAL, 2002, 62 (02) :648-653
[5]   AORTIC-VALVE DISEASE IN PATIENTS WITH WEGENERS GRANULOMATOSIS [J].
DAVENPORT, A ;
GOODFELLOW, J ;
GOEL, S ;
MACIVER, AG ;
WALKER, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (02) :205-208
[6]  
de Roux-Serratrice C, 2002, J RHEUMATOL, V29, P392
[7]  
Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131
[8]   Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [J].
Goodman, WG ;
Goldin, J ;
Kuizon, BD ;
Yoon, C ;
Gales, B ;
Sider, D ;
Wang, Y ;
Chung, J ;
Emerick, A ;
Greaser, L ;
Elashoff, RM ;
Salusky, IB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1478-1483
[9]   Vascular calcification in chronic renal failure [J].
Goodman, WG .
LANCET, 2001, 358 (9288) :1115-1116
[10]   Arterial stiffening and vascular calcifications in end-stage renal disease [J].
Guérin, AP ;
London, GM ;
Marchais, SJ ;
Metivier, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1014-1021